Plain-English translation of NCT07485075 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new smartphone app called StenoFOOD that gives personalized dietary advice to people with type 2 diabetes who also have reduced kidney function. The app helps you monitor and reduce salt and protein intake, which is important for protecting your kidneys. Researchers want to see if using this app for six months improves your health outcomes compared to standard care alone.
People with type 2 diabetes and kidney disease often need to reduce salt intake to protect their kidneys and manage blood pressure, but many struggle to make these changes on their own. This trial exists to see if a personalized digital tool can make it easier for patients to understand and follow dietary recommendations.
You likely qualify if…
You likely don't qualify if…
If you are in the intervention group, you will receive the StenoFOOD app and use it to track your salt and protein intake, get personalized dietary guidance, and monitor your health for six months. If you are in the standard care group, you will continue receiving your usual diabetes clinic visits. Either way, researchers will measure your salt intake using urine samples and check your blood pressure and kidney markers during the six-month study period.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Denmark